Severe cutaneous adverse event in a daclizumab-treated multiple sclerosis patient

Research output: Contribution to journalComment/Letter to the editorAcademic

Original languageEnglish
Pages (from-to)38-40
JournalMultiple Sclerosis and Related Disorders
Volume34
DOIs
Publication statusPublished - 2019

Cite this

@article{1eb5b4cf00b041a2b81d0a4e04441db8,
title = "Severe cutaneous adverse event in a daclizumab-treated multiple sclerosis patient",
author = "{van Rossum}, {Johannis A.} and Peters, {Marieke A. D.} and {van der Valk}, Paul and {de Jong}, {Brigit A.}",
year = "2019",
doi = "10.1016/j.msard.2019.06.006",
language = "English",
volume = "34",
pages = "38--40",
journal = "Multiple Sclerosis and Related Disorders",
issn = "2211-0348",
publisher = "Elsevier",

}

Severe cutaneous adverse event in a daclizumab-treated multiple sclerosis patient. / van Rossum, Johannis A.; Peters, Marieke A. D.; van der Valk, Paul; de Jong, Brigit A.

In: Multiple Sclerosis and Related Disorders, Vol. 34, 2019, p. 38-40.

Research output: Contribution to journalComment/Letter to the editorAcademic

TY - JOUR

T1 - Severe cutaneous adverse event in a daclizumab-treated multiple sclerosis patient

AU - van Rossum, Johannis A.

AU - Peters, Marieke A. D.

AU - van der Valk, Paul

AU - de Jong, Brigit A.

PY - 2019

Y1 - 2019

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85067385334&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/31228714

U2 - 10.1016/j.msard.2019.06.006

DO - 10.1016/j.msard.2019.06.006

M3 - Comment/Letter to the editor

VL - 34

SP - 38

EP - 40

JO - Multiple Sclerosis and Related Disorders

JF - Multiple Sclerosis and Related Disorders

SN - 2211-0348

ER -